Q4 2024 Management View Joe Sardano, Chairman and CEO, highlighted the company’s strong business momentum in 2024, driven by record sales of SRT-100 systems and the expansion of the Fair Deal ...

Paul Andrea, Chief Legal Officer at Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL), recently reported a sale of company stock ...

Vincent Vultaggio, the PAO and Interim PFO of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL), recently sold shares of the company, according to a recent SEC filing. The transaction comes as the ...

Kura Oncology (NASDAQ:KURA) stock slid 7% in post-market trading after the company issued an update on its drug ziftomenib. Kura (NASDAQ:KURA) reported positive Phase 2 data from a ...

Padmanabh P. Bhatt, Senior Vice President of Intellectual Property and Chief Scientific Officer at Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a company that InvestingPro data shows maintains ...

Acrivon Therapeutics, Inc. (ACRV) is up by 14 percent on Wednesday. The stock surged after the company announced that the U.S. Food ...

We recently published a list of 12 AI News and Ratings Investors are Keeping Their Eye On. In this article, we are going to ...

Tonix Pharmaceuticals saw its shares swing wildly between gains and losses on Wednesday morning as they started to trade ...

Regeneron's 2025 outlook includes defensive capital allocation, competitive pressure on Eylea, et cetera. Click here to read ...

TD Cowen reiterated its Buy rating and $20.00 price target for EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT). This aligns with the broader analyst consensus, as InvestingPro data shows analyst targets ...

LOS ANGELES, CA / ACCESS Newswire / February 5, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...

Tectonic Therapeutic has done well to advance its Fc-fusion protein candidate TX45 into a phase 2 study targeting patients ...